Drugmaker AstraZeneca said on Tuesday that it had received "positive high-level results" from a Phase III trial on its Enhertu candidate....
Mayne Pharma Competitors or Alternatives
Mayne Pharma's top competitors include SkyePharma, Acrux and PharmAust.
Mayne Pharma VS SkyePharma
SkyePharma has been one of Mayne Pharma's top competitors. SkyePharma's headquarters is in Saint-Quentin-Fallavier, Auvergne, and was founded in 1996. Like Mayne Pharma, SkyePharma also competes in the Pharmaceuticals field. SkyePharma generates 36% of Mayne Pharma's revenue.
Mayne Pharma VS Acrux
Acrux is one of Mayne Pharma's top rivals. Acrux is a Public company that was founded in West Melbourne, Victoria in 1998. Like Mayne Pharma, Acrux also works within the Pharmaceuticals industry. Acrux has 120 fewer employees vs. Mayne Pharma.
Mayne Pharma VS PharmAust
PharmAust is perceived as one of Mayne Pharma's biggest rivals. PharmAust was founded in 2000, and is headquartered in South Melbourne, Victoria. Like Mayne Pharma, PharmAust also competes in the Pharmaceuticals & Biotechnology sector. PharmAust generates $257.2M less revenue vs. Mayne Pharma.
Looking for similar companies to Mayne Pharma?
Similar Companies
Pharmaceuticals companies in South Australia
See 13 companies
Companies in South Australia with revenue in $100-500M rangeSee 43 companies
Pharmaceuticals & Biotechnology companies in South AustraliaSee 31 companies
Pharmaceuticals companies with revenue in $100-500M rangeSee 298 companies
Companies in Salisbury with employees in 100-250 rangeSee 305 companies
Pharmaceuticals companies in AustraliaSee 528 companies
Pharmaceuticals & Biotechnology companies with revenue in $100-500M rangeSee 569 companies
Pharmaceuticals companies in OceaniaSee 588 companies
Companies in Australia with revenue in $100-500M rangeSee 737 companies
Trending News for Mayne Pharma and Mayne Pharma's Competitors
Sandoz's antitrust suit against Amgen, the FDA's interchangeability designation for Celltrion's adalimumab biosimilar, and the inclusion of an ustekinu...
The Global Anti-aging Chinese Herbs Market report, spanning over 135+ pages, provides a comprehensive overview of the product/industry scope and outlin...
AstraZeneca Korea has recently reapplied for health insurance coverage for its PARP inhibitor Lynparza (olaparib) for the prostate cancer indication.Ko...
AstraZeneca Plc (NASDAQ:AZN) on Monday released topline data from the DESTINY-Breast09 Phase 3 trial of Enhertu (5.4mg/kg) either alone or in combinati...
Analysts at Leerink Partners said in a Monday note that DESTIN-Breast09's findings "could support an approval" for Enhertu in first-line HER2+ metastat...
Cervical Spondylosis Treatment Market is estimated to be valued at USD 6.02 Bn in 2025 and is expected to reach USD 8.82 Bn in 2032, exhibiting a compo...
The partnership, now in its second year, features a limited-edition T-shirt and the Body Check Cup in order to encourage more cancer screenings....
AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, are expected to have driven the company's top line....
A new report from Worldwide Market Report, titled "Leucocyte-Stimulating Biologics Market 2025-2032," offers an in-depth examination of the industry, i...
Frequently Asked Questions about Mayne Pharma
Who are Mayne Pharma's top competitors?
Mayne Pharma's top 3 competitors are SkyePharma, Acrux, PharmAust.Who is similar to Mayne Pharma?
SkyePharma is the most similar to Mayne Pharma. Acrux and PharmAust are also similar to Mayne Pharma.
Are Mayne Pharma and SkyePharma competitors?
Yes, SkyePharma is one of Mayne Pharma’s top competitors.